Related Experiment Video

Updated: Mar 26, 2026

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.9K

Hepatic mitochondrial dysfunction in nonalcoholic steatohepatitis: Read-out or reason?

Jonel Trebicka1,2, Robert Schierwagen2

  • 1Department of Internal Medicine I, University of Bonn, Bonn, Germany.

Hepatology (Baltimore, Md.)
|February 5, 2016
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.0K

Related Experiment Videos

Last Updated: Mar 26, 2026

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.9K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.0K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

256
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

333
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333

Articles linked to this work by shared authors, journal, and citation graph.

Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter study.

JHEP reports : innovation in hepatology·2026

First-in-human European experience with novel 22-G end-cutting fine-needle biopsy system: a prospective observational pilot study.

Clinical endoscopy·2026

Integrated Single-Cell Mass Spectrometry Imaging and Immunofluorescence Microscopy for Multimodal Characterization of Human Immune Cells.

Analytical chemistry·2026

Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.

Science advances·2026

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.

JHEP reports : innovation in hepatology·2026

Change of Left Ventricular Myocardial Contractility in Speckle Tracking Echocardiography After Transjugular Intrahepatic Portosystemic Shunt Predicts Survival.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatology (Baltimore, Md.)·2026

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

Hepatology (Baltimore, Md.)·2026

Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

Hepatology (Baltimore, Md.)·2026

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

Hepatology (Baltimore, Md.)·2026

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Hepatology (Baltimore, Md.)·2026

Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial).

Hepatology (Baltimore, Md.)·2026

Transcriptomic Analysis of Bone Marrow Adipose Tissue Reveals Enrichment in Lipid Transport in Response to Western Diet.

Endocrinology·2026

Lipoprotein X as a source of analytical and interpretative interference in routine laboratory testing.

Clinical chemistry and laboratory medicine·2026

Transforaminal lumbar interbody fusion combined with fat decompression for grade III idiopathic spinal epidural lipomatosis: a case report.

Frontiers in surgery·2026

Correction: Clinical features, diagnostic difficulties and therapeutic enlightenment of adult-onset multisystem Langerhans cell histiocytosis complicated with panhypopituitarism and central diabetes insipidus: a case report and systematic literature review.

Frontiers in oncology·2026

Treatment of obesity with liraglutide in bipolar disorder: a case report.

Frontiers in psychiatry·2026

Lipid-adiposity indices outperform traditional and derived anthropometric and biochemical indices for discriminating individuals with metabolic syndrome.

Frontiers in endocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us